| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.054 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.058 | 0.8 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |